ESC 2019 | CLARIFY: Symptoms Predict Risk Only in Patients with Prior MI

The 5-year follow up of patients with chronic stable angina (or as the guidelines currently call it “chronic coronary syndrome”) indicate the risk of cardiovascular death or non-fatal MI is quite low, but risk factor control is still fairly poor. This information comes from the CLARIFY study, presented at ESC 2019 and published simultaneously in Eur Heart J.

ESC 2019 | CLARIFY: Los síntomas predicen riesgo solamente en pacientes con infarto previo

In the general population of symptomatic patients, no association was found between angina and events, but the presence of new symptoms in patients with a history of MI significantly increased the risk of a second MI or cardiovascular death.

It seems obvious to conclude that patients with a history of MI are at higher risk, but what this study brings to the table is that even when all test outcomes result normal (ECG, SPECT, etc.) these are still high-risk patients.

The CLARIFY is aligned with the new guidelines and alerts us about the risk these patients present, saying they are not as stable as they seem.


Read also: ESC 2019 | Pure: Body Mass Index Shows Low Correlation with Cardiovascular Events.


This study enrolled 32703 patients from 45 countries with coronary artery disease considered “stable”, with symptomatic myocardial ischemia or angiographic stenosis >50%. The protocol allowed the inclusion of patients with prior MI or revascularization, as long as the event had taken place over three months earlier.

More than 95% of the population was on some antiplatelet antiaggregant, more than 80% were on statins, beta-blockers and inhibitors of the conversion enzyme/angiotensin blockers.

This seems a delicate treatment of guideline-oriented goals. However, risk factor management was poor.

Only 65% reached the conventional target of 140/90 mmHg blood pressure, only 61% reached <100 mg/dl LDL and only 42% managed to control both factors simultaneously.


Read also: ESC 2019 | HOPE 4: Overcoming Obstacles to Treat Risk Factors in Developing Countries.


If we use the threshold values recommended by the guidelines, it all gets slightly worse, seeing as just 7.4% of the population reach these targets.

After 5 years, 8% of the population presented the primary end point (cardiovascular death or non-fatal MI), that is 1.7 events rate per 100 persons/year.

Original title: Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.

Reference: Sorbets E et al. Eur Heart J. 2019; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...